Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial
bioRxiv (2021) - Comments
doi: 10.1101/2021.01.05.21249237 

Olha Holubovska, Denisa Bojkova, Stefano Elli, Marco Bechtel, David Boltz, Miguel Muzzio, Xinjian Peng, Frederico Sala, Cesare Cosentino, Alla Mironenko, Jens Milde, Yuriy Lebed, Holger Stammer, Andrew Goy, Marco Guerrini, Lutz Mueller, Jindrich Cinatl, Victor Margitich, Aartjan J. W. Te Velthuis